Survival in Primary Carcinoma of the External and Middle Ear Is Strongly Dependent on Stage at Diagnosi

DOI: 10.4236/ijohns.2013.26046   PDF   HTML     3,723 Downloads   5,298 Views   Citations


Conclusion: Early-stage detection of temporal bone carcinoma improves the survival rate. When detected at an advanced stage, predicted prognosis is poor even with a combination of surgery, radiotherapy and chemotherapy. Objectives: We evaluated treatment strategies and survival rates in cases of carcinomas of the external and middle ear. Method: Retrospective review of patients treated at Ehime University Hospital during the 32 years from 1977 to 2008. Subjects were 41 patients, consisting of 21 men and 20 women with a mean age of 63.2 years. Modified Pittsburgh staging system: stage I in 11 cases (27%), stage II in 4 (10%), stage III in 6 (15%) and stage IV in 20 (49%). Histopathology: squamous cell carcinoma (SCC) in 35 cases, adenoid cystic carcinoma (ACC) in 3, and adenocarcinoma (AC) in 3. Thirty-eight patients were treated by surgery. Radiation was added postoperatively in 23 patients. Three patients were treated by chemoradiotherapy. Results: The survival rate of carcinomas detected at an advanced stage was poor with a disease-specific 5-year survival rate of 100% in early-stage disease (stage I and II) versus 20.8% in stage III and 27.5% in stage IV disease, irrespective of histopathology of the tumor.

Share and Cite:

T. Ugumori, J. Hyodo, N. Hato and K. Gyo, "Survival in Primary Carcinoma of the External and Middle Ear Is Strongly Dependent on Stage at Diagnosi," International Journal of Otolaryngology and Head & Neck Surgery, Vol. 2 No. 6, 2013, pp. 221-227. doi: 10.4236/ijohns.2013.26046.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] S. E. Kinney and B. G. Wood, “Malignancies of the External Ear Canal and Temporal Bone: Surgical Techniques and Results,” Laryngoscope, Vol. 97, No. 2, 1987, pp. 158-164.
[2] W. I. Kuhel, C. R. Hume and S. H. Selesnick, “Cancer of the External Auditory Canal and Temporal Bone,” Otolaryngologic Clinics of North America, Vol. 29, No. 5, 1996, pp. 827-852.
[3] P. M. Stell and M. S. McCormick, “Carcinoma of the External Auditory Meatus and Middle Ear. Prognostic Factors and a Suggested Staging System,” The Journal of Laryngology & Otology, Vol. 99, No. 9, 1985, pp. 847-850.
[4] S. A. Moody, B. E. Hirsch and E. N. Meyers, “Squamous Cell Carcinoma of the External Auditory Canal: An Evaluation of a Staging System,” American Journal of Otolaryngology, Vol. 21, No. 4, 2000, pp. 582-588.
[5] C. H. Chang, M. T. Shu, J. C. Lee, Y. S. Leu, Y. C. Chen and K. S. Lee, “Treatments and Outcomes of Malignant Tumors of External Auditory Canal,” American Journal of Otolaryngology, Vol. 30, No. 1, 2009, pp. 44-48.
[6] M. Yin, K. Ishikawa, K. Honda, T. Arakawa, Y. Harabuchi, T. Nagabashi, et al., “Analysis of 95 Cases of Squamous Cell Carcinoma of the External and Middle Ear,” Auris Nasus Larynx, Vol. 33, No. 3, 2006, pp. 251-257.
[7] M. Varyberg and R. T. Sataloff, “Hearing Loss. Chapter 21. Squamous Cell Carcinoma of Temporal Bone,” R. T. Sataloff and J. Sataloff, Eds., Taylor & Francis, New York/London, 2005, pp. 545-571.
[8] H. Sugimoto, M. Ito, M. Hatano, S. Kondo, S. Suzuki and T. Yoshizaki, “Roles of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma of the Temporal Bone,” Otology & Neurotology, Vol. 32, No. 3, 2011, pp. 483-487.
[9] L. S. Pemberton, R. Swindell and A. J. Sykes, “Primary Radical Radiotherapy for Squamous Cell Carcinoma of the Middle Ear and External Auditory Canal: An Historical Series,” Journal of Clinical Oncology, Vol. 18, No. 5, 2006, pp. 390-394.
[10] A. R. Birzgalis, A. O. Keith and W. T. Farrington, “Radiotherapy in the Treatment of Middle Ear and Mastoid Carcinoma,” Clinical Otolaryngology and Allied Sciences, Vol. 17, No. 2, 1992, pp. 113-116.
[11] R. K. Gurgel, L. H. Karnell and M. R. Hansen, “Middle Ear Cancer: A Population-Based Study,” Laryngoscope, Vol. 119, No. 10, 2009, pp. 1913-1917.
[12] R. R. Gacek and M. Goodman, “Management of Malignancy of the Temporal Bone,” Laryngoscope, Vol. 87, No. 10, 1977, pp. 1622-1634.
[13] J. G. Spector, “Management of Temporal Bone Carcinomas: A Therapeutic Analysis of Two Groups of Patients and Long-Term Followup,” Otolaryngology-Head and Neck Surgery, Vol. 104, No. 1, 1991, pp. 58-66.
[14] L. Pfreundner, K. Schwager, J. Willner, K. Baier, K. Bratengeier, F. X. Brunner, et al., “Carcinoma of the External Auditory Canal and Middle Ear,” International Journal of Radiation Oncology*Biology*Physics, Vol. 44, No. 4, 1999, pp. 777-788.
[15] T. Nakagawa, Y. Kumamoto, Y. Natori, H. Shiratsuchi, S. Toh, Y. Kakazu, S. Shibata, T. Nakashima and S. Komune, “Squamous Cell Carcinoma of the External Auditory Canal and Middle Ear: An Operation Combined with Preoperative Chemoradiotherapy and a Free Surgical Margin,” Otology Neurotology, Vol. 27, No. 2, 2006, pp. 242-249.
[16] Y. Ueda, T. Kurita, Y. Matsuda, S. Ito and T. Nakashima, “Superselective, Intra-Arterial, Rapid Infusion Chemotherapy for External Auditory Canal Cartinoma,” The Journal of Laryngology & Otology, Vol. 123, No. S31, 2009, pp. 75-80.
[17] J. E. Medina, A. O. Park, G. L. Neely, et al., “Lateral Temporal Bone Resection,” American Journal of Surgery, Vol. 160, No. 4, 1990, pp. 427-433.
[18] R. T. Sataloff, D. L. Myers, L. D. Lowry and J. R. Spiegel, “Total Temporal Resection for Squamous Cell Carcinoma,” Otolaryngology-Head and Neck Surgery, Vol. 96, No. 1, 1987, pp. 4-14.
[19] M. Ito, M. Hatano and T. Yoshizaki, “Prognostic Factors for Squamous Cell Carcinoma of the Temporal Bone: Extensive Bone Involvement or Extensive Soft Tissue Involvement?” ActaOto-Laryngologica, Vol. 129, No. 11, 2009, pp. 131-139.
[20] S. Prasad and I. P. Janecka, “Efficacy of Surgical Treatments for Squamous Cell Carcinoma of the Temporal Bone: A Literature Review,” Otolaryngology-Head and Neck Surgery, Vol. 110, No. 3, 1994, pp. 270-280.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.